1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]

Verify with CMS →

darbepoetin alfa

RxCUI: 352047

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
26.8%
Plan Coverage
1,358
Plans Covering
T4.2
Avg Tier
96.5%
Prior Auth Required

What the CMS Formulary Data Shows for 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]

Per the CMS 2026 Part D formulary file, 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] (RxNorm concept RXCUI 352047, generic name darbepoetin alfa) appears on 57 distinct formulary files spanning 1,358 Medicare Part D plan offerings - 26.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.

Real-world access to 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] depends on utilization management as much as tier placement: 96.5% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,574 Part D beneficiaries filled 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] in 2023, with total plan-and-beneficiary spending of $59,909,953 and an average per-beneficiary annual cost of $10,748.11. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] today.

Coverage Details

Formularies covering
57
Plans covering
1,358
Coverage rate
26.8%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
96.5% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
5,574
Total spending
$59,909,953
Avg per beneficiary
$10,748.11

Tier Distribution Across Plans

23 plans
Tier 1, Preferred Generic
2 plans
Tier 2, Generic
75 plans
Tier 4, Non-Preferred

Standalone Drug Plans (PDP) Covering 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]

5 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
Anthem Full Dual Advantage (PPO D-SNP) ANTHEM HEALTH PLANS, INC. T4 Yes No $0 CT
Anthem Dual Advantage (PPO D-SNP) ANTHEM HEALTH PLANS, INC. T4 Yes No $0 CT
Anthem Kidney Care (HMO-POS C-SNP) ANTHEM HEALTH PLANS, INC. T4 Yes No $0 CT
Anthem Full Dual Advantage Select (HMO D-SNP) ANTHEM HEALTH PLANS, INC. T4 Yes No $0 CT
Anthem Dual Advantage (HMO D-SNP) ANTHEM HEALTH PLANS, INC. T4 Yes No $0 CT

Medicare Advantage Plans (MA-PD) Covering 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]

95 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Gold Coast Health Plan Total Care Advantage (HMO D-SNP) Ventura County Medi-Cal Managed Care Commission T1 Yes $0 CA
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) Health Care Service Corporation T1 Yes $0 NM
Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) Health Care Service Corporation T1 Yes $0 NM
SecureBlue (HMO D-SNP) HMO Minnesota T1 Yes $0 MN
Hamaspik Medicare Choice (HMO D-SNP) HAMASPIK, INC. T1 Yes $0 NY
SeniorCare Complete (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
AbilityCare (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
Alameda Alliance Wellness (HMO D-SNP) ALAMEDA ALLIANCE FOR HEALTH T1 Yes $0 CA
Community Care's Partnership Program (HMO D-SNP) COMMUNITY CARE HEALTH PLAN, INC. T1 Yes $0 WI
Platino Blindao (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
Platino Enlace (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
PLATINO ADVANCE (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
PLATINO PLUS (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $0 PA
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $0 PA
Highmark Health Options Duals (HMO D-SNP) HIGHMARK HEALTH OPTIONS WEST VIRGINIA INC. T1 Yes $0 WV
Highmark Health Options Duals (HMO D-SNP) HIGHMARK BCBSD, INC. T1 Yes $0 DE
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) HCSC INSURANCE SERVICES COMPANY T1 Yes $4.80 TX
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) GHS INSURANCE COMPANY T1 Yes $5.00 OK
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $13.10 PA
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $17.60 PA
Highmark Health Options Duals Select (HMO D-SNP) HIGHMARK BCBSD, INC. T1 Yes $31.20 DE
Hamaspik Medicare Select (HMO D-SNP) HAMASPIK, INC. T1 Yes $34.50 NY
CareAdvantage (HMO D-SNP) SAN MATEO HEALTH COMMISSION T2 Yes $0 CA
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 Yes $0 CA
Anthem Medicare Advantage (HMO-POS) BLUE CROSS OF CALIFORNIA T4 Yes $0 CA
Anthem Medicare Advantage (HMO-POS) BLUE CROSS OF CALIFORNIA T4 Yes $0 CA
Anthem Medicare Advantage (HMO-POS) BLUE CROSS OF CALIFORNIA T4 Yes $0 CA
Anthem Medicare Advantage (HMO-POS) BLUE CROSS OF CALIFORNIA T4 Yes $0 CA
Anthem Full Dual Advantage (HMO D-SNP) ANTHEM INSURANCE COMPANIES, INC. T4 Yes $0 IN
Anthem I PathWays Dual Care Advantage (HMO D-SNP) ANTHEM INSURANCE COMPANIES, INC. T4 Yes $0 IN
Anthem I PathWays Dual Care Advantage NFLOC (HMO D-SNP) ANTHEM INSURANCE COMPANIES, INC. T4 Yes $0 IN
Wellpoint Full Dual Advantage (HMO-POS D-SNP) WELLPOINT IOWA, INC. T4 Yes $0 IA
Wellpoint Full Dual Advantage 2 (HMO-POS D-SNP) WELLPOINT IOWA, INC. T4 Yes $0 IA
Wellpoint Full Dual Advantage (HMO D-SNP) WELLPOINT WEST VIRGINIA , INC. T4 Yes $0 WV
Wellpoint Full Dual Advantage (HMO D-SNP) WELLPOINT WASHINGTON, INC. T4 Yes $0 WA
Wellpoint Dual Advantage (HMO D-SNP) WELLPOINT WASHINGTON, INC. T4 Yes $0 WA
Healthy Blue Dual Advantage (HMO D-SNP) COMMUNITY CARE HEALTH PLAN OF LOUISIANA, INC. T4 Yes $0 LA
Healthy Blue Dual Advantage 2 (HMO D-SNP) COMMUNITY CARE HEALTH PLAN OF LOUISIANA, INC. T4 Yes $0 LA
Anthem Dual Advantage (PPO D-SNP) ANTHEM INSURANCE COMPANIES, INC. T4 Yes $0 VA
Wellpoint Medicare Advantage 2 (HMO-POS) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Kidney Care (HMO-POS C-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Dual Advantage 2 (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Kidney Care (HMO-POS C-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage Aligned (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage Aligned (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage Aligned (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage Aligned (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage 2 (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX
Wellpoint Full Dual Advantage 2 (HMO D-SNP) WELLPOINT TEXAS, INC. T4 Yes $0 TX

Frequently Asked Questions

Is 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] covered by Medicare Part D?

Yes, 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] is covered by 1,358 Medicare Part D plans (26.8% of all Part D formularies).

What tier is 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] on Medicare Part D plans?

1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.

Does 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] require prior authorization?

96.5% of Part D formularies require prior authorization for 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp]?

In 2023, total Medicare Part D spending on 1 ML darbepoetin alfa 0.1 MG/ML Injection [Aranesp] was $59,909,953, covering 5,574 beneficiaries. The average spend per beneficiary was $10,748.11.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial